Jane Street’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$715K Buy
+22,200
New +$822K ﹤0.01% 7237
2025
Q4
Sell
-79,900
Closed -$2.74M 12478
2025
Q3
$2.74M Buy
+79,900
New +$2.29M ﹤0.01% 4378
2025
Q1
Sell
-8,200
Closed -$325K 10686
2024
Q4
$325K Buy
+8,200
New +$310K ﹤0.01% 7611
2023
Q4
Sell
-11,900
Closed -$266K 9853
2023
Q3
$266K Buy
+11,900
New +$306K ﹤0.01% 7245
2023
Q1
Sell
-10,300
Closed -$244K 9995
2022
Q4
$244K Sell
10,300
-23,800
-70% -$553K ﹤0.01% 7359
2022
Q3
$566K Buy
34,100
+17,600
+107% +$396K ﹤0.01% 6461
2022
Q2
$328K Buy
16,500
+1,400
+9% +$28.3K ﹤0.01% 7471
2022
Q1
$416K Buy
+15,100
New +$432K ﹤0.01% 7820

Other funds holding VCYT

Jane Street's VCYT Position: Q3 2025 in Review

Jane Street sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 296,264 shares — an estimated $8.5M sold.

Jane Street first reported a position in VCYT in Q4 2018 and held it in 20 quarters. The position peaked at $10.3M in Q3 2024. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Jane Street reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 296,264 Veracyte shares in Q3 2025, an estimated $8.5M.
  • Jane Street first reported a position in Veracyte in Q4 2018 and held it in 20 quarters.
  • Jane Street's Veracyte position peaked at $10.3M in Q3 2024.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.